TORONTO — Halifax will host a Davis Cup World Group I tie between Canada and Israel on Sept. 12-13, Tennis Canada announced Thursday. The matchup at Scotiabank Centre will decide which nation ...

Bank of Nova Scotia expects its stake in KeyCorp will contribute about 62 million Canadian dollars ($44.7 million) in net income contribution for the fiscal second quarter. The figure includes ...

Dr. Manjusha Goel further explained when and how new mothers can start working out: First 48 hours post-delivery: In the first 24 hours after surgery, mothers may still feel the effects of spinal ...

TSE:BCE opened at C$30.47 on Wednesday. BCE has a twelve month low of C$28.73 and a twelve month high of C$49.13. The company has a market capitalization of C$27.60 billion, a P/E ratio of 102.22 ...

(Pic credit: PTI) Appearing for the Centre, solicitor general Tushar Mehta said a large section of Muslims did not want to be governed by the Waqf Act. This led the bench to ask, "Are you saying ...

HALIFAX - Bill Zonnon had a goal and assist ... Maritimes Junior Hockey League playoff action on Tuesday night at Scotiabank Centre. Remi Gelinas, Lars Steiner and Alex Carr also scored for ...

A new Dalhousie initiative that seeks to diversify the field of digital transformation so that it engages and benefits everyone has received vital support through a $1-million gift from Scotiabank.

Indie singer-songwriter Vance Joy is kicking off a 2025 North American tour on Tuesday, August 26 at Scotiabank Centre in Halifax, Nova Scotia. The “Riptide” star will continue to play ...

The matter would come up on May 6. Asking the Centre to consider the proposition of an expert agency, the bench allowed it to move court early for an appropriate direction. The top court was ...

EQB has a twelve month low of C$78.24 and a twelve month high of C$114.22. The stock has a market capitalization of C$3.94 billion, a P/E ratio of 15.87, a P/E/G ratio of 0.34 and a beta of 1.59.

Scotiabank raised the firm’s price target on INmune Bio (INMB) to $23 from $22 and keeps an Outperform rating on the shares.The company’s management appears confident a Biologics License ...